Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > Expect the SP to sink below $0.40 going forward.
View:
Post by StockscoutX on Jul 14, 2021 11:05am

Expect the SP to sink below $0.40 going forward.

Do you really think that making a few millions, maybe less, of revenues per quarter justifies a valuation of over $100 million and maybe more for StageZero? Ludicrous at best.

StageZero is turning out to be a small time business at best with a small market share if ever.

It what happens when those at the helm thinks small and increasing shareholder value doesn't seem to exist in their priorities.
Comment by frewil11 on Jul 14, 2021 11:09am
I agree the Q2 results will be decent , but if it goes up or down doesn't really matter , its all about getting Aristotle number of tests increasing quarter over quarter. 
Comment by Liked2Think on Jul 14, 2021 12:14pm
1.7-1.9M is better than decent but no one cares. All it shows is a gradual decline in revenue from a high of Q4. Even with all the other good looking possibilities why would anyone invest in something that is declining when there is no proof that aristotle will do anything. What happened to gap boy?  Remember that thing calling for .35-.45 back when we were a buck.  Everyone thought ...more  
StageZero Life Sciences Ltd